First direct evidence that environmental oestrogens affect sperm fertilityJune 30, 2002Researchers have found the first evidence that oestrogens from the environment, and also ones that occur naturally in our bodies, significantly affect the fertilising ability of sperm. Prof Lynn Fraser told the annual conference of the European Society of Human Reproduction and Embryology in Vienna today (Tuesday 2 July) that environmental oestrogens appeared to have a far greater impact on a sperm's ability to function than natural oestrogens. Although the environmental oestrogens were normally 1,000 times less biologically potent than the natural oestrogens, they could be 100 times more potent in sperm. This suggested that they might operate in a different way to naturally occurring oestrogens. Prof Fraser, who is Professor of Reproductive Biology at Kings College London, England, and a former chairman of ESHRE, investigated how three environmental oestrogens and one natural oestrogen affected the final stage of development of sperm when it acquires the ability to fertilise an egg - this stage is known as capacitation. Prof Fraser and her team studied this effect in mouse sperm in the test tube (in vitro). The environmental oestrogens were genistein (G), found in soya and other legume vegetables, 8-prenylnaringenin (8-PN), found in hops, and nonylphenol (NP), found in industrial products such as synthetic cleaners, paints, herbicides and pesticides. The natural oestrogen was oestradiol 17ß (E2), which is present in the female vagina and in seminal plasma (the fluid containing the sperm). In sperm, which had not completed capacitation, all the oestrogens accelerated development so that they became fertile more quickly. The oestrogens stimulated sperm motility, capacitation and the acrosome reaction (when the cap at the head of the sperm ruptures to release enzymes which enable the sperm to penetrate the barriers surrounding the egg). In sperm which were already capacitated, the natural oestrogen had no significant effect, but all the environmental oestrogens significantly stimulated the acrosome reaction. It is important to note that successful sperm only undergo the acrosome reaction when they make contact with an egg; if they have already undergone the acrosome reaction before contact, then they cannot fertilise an egg. Prof Fraser said: "At first sight these results might suggest that oestrogens, particularly those found in the environment, could help fertility. However, the responses we have seen could have negative effects over time. For instance, the fact that the oestrogens stimulated uncapacitated cells in an unregulated manner could mean that the sperm peak too soon, before they have found an egg to fertilise. So in natural reproduction it could be a problem, but for IVF techniques it might be a benefit. Now we need to know what actually happens in human sperm and in vivo, and whether compounds known to be in the seminal plasma might counteract the effects of the environmental oestrogens." The researchers want to investigate the effect on sperm of a combination of environmental oestrogens. Prof Fraser said: "In real life, it is quite possible that we could be exposed to more than one of these compounds, as in a beer-drinking, vegetarian painter or farmer, for example. We want to know if the responses are even greater when we use more than one of these environmental oestrogens. My suspicion is that combinations of environmental oestrogens, even in very weak amounts, would still have a significant effect. "Other studies, using indirect tests that do not assess actual sperm function, have reported that oestrogens affect sperm. Our study is the first to provide both indirect and direct evidence that natural and environmental oestrogens significantly affect sperm fertilising ability. These findings could be important in understanding how different compounds, known to be present in our environment, might affect sperm function in humans. Given that the environmental oestrogens are very potent and that we are probably being exposed to several at the same time, it is important to know whether they might have cumulative effects." (ends) Abstract no: 0-119 (Tuesday 11.15 hrs CET. Hall E2) URL: http://conf.eshre.com/PDF/O-119.pdf | |||||||||||||||||||||
|
Related Estrogen Current Events and Estrogen News Articles Why the 'perfect' body isn't always perfect Having an imperfect body may come with some substantial benefits for some women, according to a new article in the December issue of Current Anthropology. Estrogen therapy could be dangerous for women with existing heart risk Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. Migraines associated with lower risk of breast cancer Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Scientists identify new gene responsible for puberty disorders A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers. Birth control has long-term effect on hormone exposure Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life. Clue to genetic cause of fatal birth defect A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine. Bisphenol A linked to chemotherapy resistance Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. Tamoxifen chemoprevention tied to early detection of breast cancer The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. Herbal Menopause Therapy a Good Fit for Breast Cancer Patients? When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer. More Estrogen Current Events and Estrogen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||